Drug profile · INN
hepatitis b (rdna) vaccine (adjuvanted, adsorbed)
FENDRIX
hepatitis b (rdna) vaccine (adjuvanted, adsorbed) (FENDRIX) is a surface antigen (hbsag) vaccine antigen.
EMA: approved Antiinfectives for systemic use (J07) J07BC01
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — hepatitis b (rdna) vaccine (adjuvanted, adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
hepatitis b (rdna) vaccine (adjuvanted, adsorbed) (FENDRIX) is a surface antigen (hbsag) vaccine antigen.
Key facts
INN hepatitis b (rdna) vaccine (adjuvanted, adsorbed)
Brand FENDRIX
Mechanism Surface antigen (HBsAg) vaccine antigen
Target Surface antigen (HBsAg)
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BC01
Mechanism of action
Surface antigen (HBsAg) vaccine antigen
Primary target: Surface antigen (HBsAg)
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hepatitis b (rdna) vaccine (adjuvanted, adsorbed)?
hepatitis b (rdna) vaccine (adjuvanted, adsorbed) (FENDRIX) is a surface antigen (hbsag) vaccine antigen.
What is the brand name for hepatitis b (rdna) vaccine (adjuvanted, adsorbed)?
FENDRIX is a marketed brand name for hepatitis b (rdna) vaccine (adjuvanted, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.